This is the reason for the buying i think: Morgan Stanley slaps $1.30 share price target on Nearmap Ltd https://www.fool.com.au/2018/01/31/why-shares-of-nearmap-ltd-are-up-over-3-today/
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025